Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 30.98%19.84B | 20.29%10.17B | 41.04%15.15B | 5,925.48%8.45B | 22,118.16%10.74B | 17,470.51%3.78B | 1,055.86%140.26M | 2,430.99%119.31M | 246.98%48.34M | 132.19%21.51M |
| Operating income | 30.98%19.84B | 20.29%10.17B | 41.04%15.15B | 5,925.48%8.45B | 22,118.16%10.74B | 17,470.51%3.78B | 1,055.86%140.26M | 2,430.99%119.31M | 246.98%48.34M | 132.19%21.51M |
| Cost of sales | -30.92%-19.72B | -20.24%-10.13B | -40.97%-15.07B | -6,630.77%-8.42B | -31,278.81%-10.69B | -23,072.33%-3.75B | -1,110.35%-125.14M | -2,507.41%-110.87M | -261.00%-34.06M | -200.43%-16.2M |
| Operating expenses | -30.92%-19.72B | -20.24%-10.13B | -40.97%-15.07B | -6,630.77%-8.42B | -31,278.81%-10.69B | -23,072.33%-3.75B | -1,110.35%-125.14M | -2,507.41%-110.87M | -261.00%-34.06M | -200.43%-16.2M |
| Gross profit | 41.11%116.76M | 34.47%38.77M | 53.79%82.74M | 90.60%28.83M | 276.65%53.8M | 378.06%25.38M | 742.20%15.13M | 1,727.71%8.44M | 217.56%14.28M | 37.15%5.31M |
| Profit from asset sales | ---- | ---- | -102.87%-45K | ---- | --1.57M | ---- | ---- | ---- | ---- | ---- |
| Employee expense | -10.64%-12.27M | -3.86%-6.22M | -3.17%-11.09M | -16.69%-5.98M | 18.38%-10.75M | 24.86%-7.78M | 27.00%-5.13M | 28.29%-2.61M | 28.84%-13.17M | 25.05%-10.35M |
| Depreciation and amortization | 18.12%-3.82M | 21.84%-2.02M | -32.17%-4.66M | -55.21%-2.58M | 2.19%-3.53M | 8.43%-2.42M | 11.55%-1.66M | 6.29%-894K | 8.78%-3.6M | 11.06%-2.65M |
| Revaluation surplus | ---- | ---- | ---- | ---- | 111.76%20K | ---- | ---- | ---- | ---170K | --50K |
| -Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | 111.76%20K | ---- | ---- | ---- | ---170K | --50K |
| Impairment and provision | 73.62%-593K | -431.38%-1.27M | -598.14%-2.25M | -17.16%-239K | -50.47%-322K | -164.81%-429K | -537.50%-204K | 167.65%46K | -7.00%-214K | 26.70%-162K |
| -Other impairment is provision | 73.62%-593K | -431.38%-1.27M | -598.14%-2.25M | -17.16%-239K | -50.47%-322K | -164.81%-429K | -537.50%-204K | 167.65%46K | -7.00%-214K | 26.70%-162K |
| Special items of operating profit | 48.20%-8.5M | 56.82%-4.41M | -39.46%-16.42M | -90.43%-10.21M | 21.60%-11.77M | 28.37%-8.17M | 34.81%-5.36M | 55.39%-2.17M | -17.04%-15.02M | -71.17%-11.41M |
| Operating profit | 89.66%91.58M | 153.05%24.86M | 66.39%48.28M | 254.15%9.82M | 262.22%29.02M | 134.23%6.58M | 118.12%2.77M | 131.25%2.82M | 42.27%-17.89M | 2.98%-19.21M |
| Financing cost | -809.86%-7.29M | 68.28%-131K | 23.71%-801K | -5.09%-413K | -379.45%-1.05M | -823.68%-702K | -614.55%-393K | -655.17%-219K | -67.18%-219K | 17.39%-76K |
| Share of profits of associates | ---- | ---- | ---- | ---- | 67.58%-1.55M | 54.28%-1.55M | 98.39%-30K | 92.83%-33K | -1,166.40%-4.79M | -3,592.78%-3.39M |
| Special items of earning before tax | -466.67%-17K | ---- | ---3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 77.49%84.27M | 162.77%24.73M | 79.73%47.48M | 300.30%9.41M | 215.38%26.42M | 119.08%4.33M | 113.64%2.35M | 126.99%2.56M | 27.32%-22.9M | -14.54%-22.68M |
| Tax | -26.23%-19.36M | -58.32%-7.35M | -69.60%-15.34M | -58.68%-4.64M | -3,261.34%-9.04M | ---4.87M | ---2.93M | ---1.69M | -293.53%-269K | ---- |
| After-tax profit from continuing operations | 101.94%64.91M | 264.47%17.38M | 85.01%32.15M | 929.22%4.77M | 175.01%17.38M | 97.60%-544K | 96.66%-575K | 109.18%872K | 26.14%-23.16M | -14.52%-22.68M |
| Earning after tax | 101.94%64.91M | 264.47%17.38M | 85.01%32.15M | 929.22%4.77M | 175.01%17.38M | 97.60%-544K | 96.66%-575K | 109.18%872K | 26.14%-23.16M | -14.52%-22.68M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.48%-1.09M | 30.20%-1.04M |
| Profit attributable to shareholders | 101.94%64.91M | 264.47%17.38M | 85.01%32.15M | 929.22%4.77M | 178.71%17.38M | 97.49%-544K | 96.45%-575K | 110.31%872K | 24.30%-22.07M | -18.16%-21.64M |
| Basic earnings per share | 69.85%0.0659 | 206.90%0.0178 | 84.76%0.0388 | 928.57%0.0058 | 178.95%0.021 | 97.32%-0.0007 | 96.41%-0.0007 | 110.78%0.0011 | 32.32%-0.0266 | -1.56%-0.0261 |
| Diluted earnings per share | 69.85%0.0659 | 206.90%0.0178 | 84.76%0.0388 | 928.57%0.0058 | 178.95%0.021 | 97.32%-0.0007 | 96.41%-0.0007 | 110.78%0.0011 | 32.32%-0.0266 | -1.56%-0.0261 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | -- | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.